A Colorado Collateral License Agreement between Gentling, Inc. and The University of North Texas Health Science Center is a legal document outlining the terms and conditions under which Gentling can obtain a license to use and commercialize any collateral generated from research or intellectual property developed at The University of North Texas Health Science Center. This agreement ensures the protection of the university's intellectual property rights while allowing Gentling to benefit from and further develop these inventions or discoveries. The Colorado Collateral License Agreement serves as a means to facilitate research collaboration between the two parties and enables Gentling to leverage the knowledge, expertise, and resources available at The University of North Texas Health Science Center. The agreement defines the scope of the licensed collateral, which may include patents, trademarks, copyrights, trade secrets, or any other form of intellectual property. The agreement explicitly outlines the rights and responsibilities of both Gentling and The University of North Texas Health Science Center. It may require Gentling to provide regular progress reports, disclose any improvements made to the collateral, and share commercialization plans. The agreement also ensures that any resulting revenue generated from the licensed collateral is fairly distributed between the parties involved. Different types of Collateral License Agreements may exist depending on the nature of the intellectual property being licensed. These include exclusive licenses, where Gentling would have sole rights to use and commercialize the collateral, or non-exclusive licenses, which allow The University of North Texas Health Science Center to grant similar rights to other entities. Furthermore, the agreement may specify the duration of the license, termination conditions, and dispute resolution procedures. In summary, the Colorado Collateral License Agreement between Gentling, Inc. and The University of North Texas Health Science Center is a comprehensive legal framework that supports the collaboration and commercialization of intellectual property. It ensures proper management of the collateral generated during research, benefits both parties involved, and promotes the advancement of scientific knowledge and innovation.